Request a demo today!
See the Atellica® VTLi Patient-side Immunoassay Analyzer firsthand. We would be happy to schedule a demo for you.
Overview
For emergency care professionals, swift decision-making is vital to improving patient outcomes. Join our webinar to learn from leading experts about the latest advancements in cardiac emergency care, focusing on the rapid diagnosis of suspected acute myocardial infarction. Discover the safety and effectiveness of a novel 0–2-hour diagnostic algorithm using high-sensitivity troponin assays and gain practical advice on implementing point-of-care technology. Plus, engage directly with authors of key clinical trials in a live Q&A session.
Learning Objectives
- Explore the first report of a 0-/2-hour strategy using a POC hs-cTn assay validated in whole blood.
- Understand the safety and effectiveness of the 0–2-hour algorithm with the Atellica® VTLi hs-cTnI assay, supported by prospective observational studies in the U.S. and Australia.
- Gain insights from Professor Louise Cullen and Dr. Fred Apple on adopting POC high-sensitivity troponin, addressing challenges in both the lab and emergency department.
Who Should Attend?
- Emergency physicians
- Laboratory personnel
- Cardiologists
- Nurses
- Paramedics and EMTs
Speaker Information
Professor Louise Cullen: MBBS (Hon), FACEM, FESC, PhD
Professor Cullen is a renowned expert in emergency medicine, with a particular focus on acute cardiac care. Based in Brisbane, Australia, she has made significant contributions to the development of diagnostic pathways in the emergency department. Her work has been instrumental in improving the rapid diagnosis and treatment of patients with suspected acute coronary syndrome. Prof. Cullen is a Fellow of the Australian College of Emergency Medicine and the European Society of Cardiology.
Dr. Fred Apple: Medical Director Clinical & Forensic Toxicology Laboratory Hennepin Healthcare/Hennepin County Medical Center
Professor Apple is a leading clinical chemist and researcher in Laboratory Medicine from the United States, renowned globally for his expertise in cardiac biomarkers and his contributions related to cardiac troponin assays. His research has shaped the understanding and implementation of high-sensitivity cardiac troponin assays, greatly influencing how acute myocardial infarction and injury is diagnosed and managed in emergency settings; including assessing short band long term risk outcomes. Professor Apple serves as a principal investigator at the Hennepin Healthcare Research Institute in his CLIA certified Cardiac Biomarkers Trials Lab, is Medical Staff at Hennepin Healthcare/Hennepin County Medical Center in the Department of Laboratory Medicine and Pathology, is Professor at the University of Minnesota Department of Laboratory Medicine and Pathology, and an Associate Editor for the journal Clinical Chemistry. His is also a Fellow of the American College of Sports Medicine.